SRTS (Sensus Healthcare) Other Current Payables: $0.00 Mil (As of Mar. 2026)


SRTS Sensus Healthcare Inc SRTS
74 GF Score
Price $3.08
GF Value $2.77
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Sensus Healthcare Other Current Payables?

Sensus Healthcare SRTS +0.82% 74 Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus rates SRTS with a GF Score™ of 74/100 and a GF Value™ of $2.77 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Sensus Healthcare's Other Current Payables for the quarter that ended in Mar. 2026 was $0.00 Mil.

Sensus Healthcare Other Current Payables Related Terms

Sensus Healthcare Other Current Payables Historical Data

* Premium members only.

The historical data trend for Sensus Healthcare's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensus Healthcare Other Current Payables Chart

Sensus Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sensus Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SRTS
74GF Score
Sensus Healthcare Inc SRTS
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensus Healthcare Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Sensus Healthcare (SRTS) has a Other Current Payables of $0.00 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Sensus Healthcare and its competitors.
Is Sensus Healthcare's Other Current Payables too high?
Sensus Healthcare's current Other Current Payables is $0.00 Mil. Overall, Sensus Healthcare has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sensus Healthcare's Other Current Payables compare to COCH and QTI?
Sensus Healthcare's Other Current Payables of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Sensus Healthcare and its competitors. Sensus Healthcare's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensus Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sensus Healthcare (SRTS) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.77, compared to a current price of $3.08 — trading 11.2% above its estimated fair value. The current Other Current Payables is $0.00 Mil. Sensus Healthcare's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Sensus Healthcare (SRTS), the current Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sensus Healthcare (SRTS) Overvalued in 2026?

Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued. The current stock price of $3.08 is trading 11.2% above its estimated GF Value™ of $2.77. GuruFocus considers Sensus Healthcare to be Modestly Overvalued.

Key valuation signals for SRTS:

  • Other Current Payables: $0.00 Mil
  • GF Value™: $2.77 vs. price of $3.08 (11.2% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensus Healthcare Business Description

Other Exchanges 5TX:Germany
Address 851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
74GF Score

Get the complete analysis for SRTS

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.08
Price
$2.77
GF Value